Kevin Hern: “To save myself from making this same mistake, I would like to yield my time to a gentleman who has a great deal of…”

I will always advocate for those who are suffering from a rare disease and support efforts to bring treatments for these diseases to market.

When you’re spending at twice the rate of what your revenue growth is, that’s a problem.

I’ve not heard anyone say they don’t want to cut anything. It’s just that they don’t like Elon.

One way to do this is by reducing the regulatory burden so that Title IV-B funding recipients can spend more time helping children and families, and less time waiting through the red tape.